Literature DB >> 6190060

[Resection of juxtahilar bile duct carcinoma instead of palliative drainage of the biliary tract].

R Pichlmayr, L Lehr, H Ziegler.   

Abstract

Instead of the widely recommended approach of treating hilar carcinoma of the bile ducts by simple palliative biliary drainage, step by step a policy of primarily aiming at resection for cure has been adopted. So far in 11 out of 22 patients excision of the tumor was possible by resection of the hepatic duct confluence; in 4 cases a left hemihepatectomy had to be added because of carcinomatous infiltration of the left liver lobe or the left hepatic artery. The multiple bile duct openings remaining after resection of such tumors were reconstructed to one or two orifices and a bi- or unilateral Roux-en-Y cholangiojejunal anastomosis performed. In further 3 cases orthotopic liver transplantation was necessary to remove all visibly infiltrated tissue. In the remaining 8 patients because of documented extrahepatic carcinomatous spread palliative biliary drainage by a percutaneous U-tube or an endoprothesis was indeed considered the only reasonable measure. Despite the relatively high resectional rate of 60% and the extensive operations performed early mortality was confined to one patient who succumbed to septic endocarditis 6 weeks after the operation. At present the longest postoperative interval without recurrence amounts to 3 1/2 years. Nine patients free of recurrent disease are in perfect health; in 3 patients in whom a recurrence was observed after 1/2, 1 1/2 and 2 years meanwhile palliation was perfect. In contrast all patients with unresected tumors but carrying draining stents suffered from cholangitis and after 1 1/2 years all but one had died. In conclusion resectional therapy for hilar carcinoma seems possible with acceptable risk. Since only resection can provide potential cure and also palliation was better than that achieved by draining tubes a more aggressive attitude to the treatment of these lesions is advocated from our experience.

Entities:  

Mesh:

Year:  1983        PMID: 6190060     DOI: 10.1007/bf01257314

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  17 in total

1.  U tube drainage in the palliative therapy of carcinoma of the main hepatic duct junction.

Authors:  J Terblanche; J H Louw
Journal:  Surg Clin North Am       Date:  1973-10       Impact factor: 2.741

2.  Prolonged palliation in carcinoma of the man hepatic duct junction.

Authors:  J Terblanche; S J Saunders; J H Louw
Journal:  Surgery       Date:  1972-05       Impact factor: 3.982

3.  Carcinoma at the junction of the main hepatic ducts.

Authors:  M J Whelton; M Petrelli; P George; W B Young; S Sherlock
Journal:  Q J Med       Date:  1969-04

4.  Carcinoma of the bile ducts.

Authors:  C D Lees; A Zapolanski; A M Cooperman; R E Hermann
Journal:  Surg Gynecol Obstet       Date:  1980-08

5.  The use of silastic transhepatic stents in benign and malignant biliary strictures.

Authors:  J L Cameron; B W Gayler; G D Zuidema
Journal:  Ann Surg       Date:  1978-10       Impact factor: 12.969

6.  Treatment of carcinoma of the biliary system.

Authors:  Y Iwasaki; M Ohto; T Todoroki; T Okamura; A Nishimura
Journal:  Surg Gynecol Obstet       Date:  1977-02

7.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02

8.  Evaluation of aggressive surgery for carcinoma of the extrahepatic bile ducts.

Authors:  A Evander; P Fredlund; J Hoevels; I Ihse; S Bengmark
Journal:  Ann Surg       Date:  1980-01       Impact factor: 12.969

9.  Surgical treatment of adenocarcinoma. Location: junction of the right, left, and common hepatic biliary ducts.

Authors:  O E Akwari; K A Kelly
Journal:  Arch Surg       Date:  1979-01

Review 10.  Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases.

Authors:  K Okuda; Y Kubo; N Okazaki; T Arishima; M Hashimoto
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

View more
  2 in total

1.  Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer.

Authors:  R Pichlmayr; B Ringe; W Lauchart; W O Bechstein; G Gubernatis; E Wagner
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

2.  [Surgical therapy of hilar cholangiocarcinoma].

Authors:  H Lang; G M Kaiser; T Zöpf; G C Sotiropoulos; A Frilling; M Malagó; C E Broelsch
Journal:  Chirurg       Date:  2006-04       Impact factor: 0.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.